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The Clinical Question: PICOT 
Traumatic brain injury (TBI) often has serious consequences over the long term (Reddy et al., 
2014) and is typically a result of acceleration-deceleration accidents, athletic trauma or blasts 
(Kerson, 2014). Consequences of TBI often profoundly impact daily quality of life, especially in 
first responders and veterans and are manifested as sustained physical, cognitive, emotional 
and behavioral problems (Lafee, 2017). While therapies have been in existence for decades, 
evidence is inconsistent and lacking regarding alternative modalities, such as neurofeedback 
training (NFT). IASIS microcurrent neurofeedback (MCN) is a more recently developed 
contemporary technology as compared to traditional NFT that has been used for the past several 
decades. A wide body of anecdotal evidence supports the effectiveness of MCN for treating TBI 
(Shallenberger, 2018). Advantages of MCN over traditional neurofeedback include (a) it is the 
first technology demonstrating effectiveness using image-based evidence, (b) sessions are 
shorter in duration, and (c) sustainability of positive outcomes occur sooner (IASIS, 2018). 
However, NFT has been around for decades and has also demonstrated effectiveness. This led 
to a spirit of inquiry by a group undergraduate nursing research students to compare TBI 
outcomes using the newer MCN therapy with the more traditional NFT in persons with mild TBI 
(mTBI). 
The literature search was guided by the following PICOT question: In patients with mTBI (P), 
how does MCN therapy (I) compared to NFT therapy (C) affect the reduction of TBI cognitive 
symptoms (O) within the therapy’s duration (T)?  For the intervention style question, the 
hierarchy evidence is rated from Level I to Level VII. The literature review culminated in 
evidence located that reflected Levels 1, 2, 3 and 7. 
Critical Appraisal of the Evidence
Level 1: NFT A systematic study (May et al., 2013) 
reviewed 23 studies that explored effects of NFT on 
TBI.  All reviewed reports showed improvements in 
mild-moderate TBI with both subjective and objective 
data.
Level 2: NFT Rostani et al. (2017) studied effects of 
NFT with mild TBI in 17 patients, 8 in intervention and 5 
in control groups. No significant effects on memory and 
concentration. 
Level 3: NFT Munivenkatappa et al. (2014) tested 
EEG—NFB on 2 subjects, aged 12 and 20 to see 
effects on white and grey brain matter; 20 sessions, 
3/week; . Both were significantly enlarged post NFT, 
indicating improved cognitive functioning.
Level 3: NFT Reddy et al. (2014) studied NFT on QOL 
on 60 subjects; QOL significantly improved after 20 
sessions 95-6/week). 
Level 3: MCN Huang et al. (2017): first and only MCN 
due to newness; low intensity pulse transcranial 
electrical stimulation (LIP-tES) treatment that monitors 
brain waves, utilizing magnetoencephalography (MEG) 
exams for neuroimaging; Six with 1 drop out; all except 
drop out showed significant improvement in TBI-related 
post concussive symptoms. 
Level 7: NFT   Reid-Chung et al. (2015) demonstrated 
through three clinical case studies that a combination of 
biofeedback and NFT “can” improve heart rate 
variability with those who have TBI. Kerson, 2014) 
discussed an interview with the President of 
International Society for Neurofeedback and Research 
who stated too few academics are interested in 
research and research that has been done lacks rigor 
due to lack of collaboration with those knowledgeable 
about and skilled in NFT. Gray (2017) discusses a 
newer generation of NFT, quantitative EEG (qEEG) that 
helps to improve clinical sensitivity; current evidence 
flawed and lacks rigor.
Problem Identification
The Evidence: MCN or NFT?
The one MCN study and three research articles located within the past six years 
lacked significant rigor and consequently led the reviewers to question results. 
Small sample sizes, lack of sham for control, lack of control group, lack of 
randomization, lack of transparency regarding other methodological issues 
(protocols, length of treatment, inclusion criteria), sample heterogeneity, and 
variability in length of time post TBI all contributed to weak internal and external 
validity. According to Shallenberger (2018), MCN does more than treat the 
symptoms….MCN repairs the underlying neurological mechanisms contributing 
to the devastating symptoms of PTSD and TBI. There is a critical lack of science 
to validate the scientific effectiveness to be able to promote MCN as something 
to once again give hope and meaning to the lives of thousands of veterans 
suffering from TBI and PTSD. With the one study at UC San Diego in progress 
with the veteran population, and two additional ones planned to be implemented 
in late May 2019 in East Texas, efforts will be maximized to ensure these studies 
reflect optimal internal and external validity. NFT research has been in progress 
for decades, but the research on TBI in the past six years is extremely limited 
and significantly lacks rigor. 
Due to the lack of evidence and lack of rigor in existing research, no decision 
can be made as to whether or not IASIS MCN or NFT is more effective. In order 
to establish evidence sound enough for practice, the following must be 
incorporated into future studies: a) larger and more homogenous samples, b)
Double blind studies with a sham treatment therapy using subjects with a variety 
of age groups and genders, c) outcomes that combine the use of imaging e.g. 
the  MEG (Huang, 2017) along with appropriate psycho-social and cognitive 
functioning tools, d) longitudinal studies to explore sustainability of interventions 
post treatment, e) transparency of protocols and equipment used and 
consistency of their use within studies.  
Implications for East Texas
This evidence-based practice project is extremely relevant to East Texas due to the 
large numbers of combat veterans in this area. Percentages of veterans battling PTSD 
are as follows:  Vietnam War 31%, Gulf War 12-24%, Iraq War 11-30% and Afghan War 
14%.  The suicide rate for veterans is 1 in 20 and only 14% of those who need help are 
actually getting it, with 40% determined to be unresponsive to treatments considered 
evidenced based (Project Healing Heroes, DU). We know there are major gaps in 
accessing quality care through the VA system and this is for many veterans their only 
viable source of healthcare. TBI and post concussive symptoms are extremely difficult 
to treat in military personnel, and these consequences are all too frequently observed 
in veterans who are homeless, jobless, have few if any, social contacts, and essentially 
have lost their purpose or meaning in life. With the advent of the relatively new MCN, 
certified practitioners report overwhelmingly positive anecdotal evidence regarding the 
effectiveness of MCN in military personnel suffering from TBI.  Anecdotal evidence also 
contributes to MCN potentially being more effective to the “treatment resistant” veteran 
suffering from TBI and PTSD. The reviewers of this EBP project firmly believe that we 
have an ethical and professional obligation to meet the needs of those who serve to 
protect our country and who seemingly have the most problems accessing quality care. 
Evidence Integrated with Clinical Expertise and 
Patient Preferences to Inform a Practice Change 
Decision
Due to very limited evidence for both MCN and traditional NFB, and lack of study 
rigor in those that are published, no practice decision can be made at this time. This 
leads to the conclusion that more Level 2 research is needed and must be conducted 
to meet criteria for internal and external validity. A VA-funded, double-blinded, 4 year 
RCT is entering its 2nd year at University of CA, San Diego to determine the effects of 
MCN on TBI and PTSD in combat veterans.  
TRADITIONAL NFT
NOTE: While this review did not focus on veterans with TBI, it was spurred by the passion of the 
primary author to address the major problem of PTSD experienced by veterans in our community. 
Three IASIS providers in Tyler have treated veterans with seemingly hopeless futures with incredible 
results. While the published evidence is favorable toward NFT, there are clear advantages of IASIS 
MCN over traditional NFT as indicated in the tables below.  The special population of veterans and 
Active Duty military personnel are underserved and when considering the sacrifices on their part 
made on behalf of our country and communities, it is incumbent on us to facilitate credible and 
rigorous scientific evidence in order to have available more effective strategies to positively impact 
their daily quality of life. It is the least we can do.
IASIS MCN
IASIS MCN
Subject can be passive and engaged in 
activity, e.g. reading, or just relax; no 
interaction required; Only 1 published pilot 
study with few rigor flaws; Evidence image-
based per MEG that showed significant 
improved brain electrical activity; Results are 
seen sooner; Enduring sustainability attained 
sooner; Anecdotal evidence that veterans with 
extreme moderate, early-severe PTSD are 
improved.
NFT
Requires interaction and concentration by 
person receiving it; Longer history of evidence of 
effectiveness, but published studies lack rigor on 
many levels; One study showed white and grey 
matter growth; May take several sessions longer 
to see results; Difficult to determine due to lack 
of anecdotal or evidence; Not recommended for 
anyone with severe TBI due to anticipated 
ineffectiveness (Homecoming for Veterans, DU).
